Why is it important to monitor neutrophil counts during chemotherapy?

Why is it important to monitor neutrophil counts during chemotherapy?

• A. To assess liver function
• B. To evaluate kidney performance
• C. To identify the risk of infection due to neutropenia
• D. To determine the efficacy of the chemotherapy

Answer: (C)

Monitoring neutrophil counts during chemotherapy is crucial primarily to identify the risk of infection due to neutropenia. Chemotherapy often targets rapidly dividing cells, which include not only cancer cells but also normal cells in the bone marrow that produce neutrophils. Neutrophils play a vital role in the body's immune response, particularly in fighting off infections. When neutrophil levels decrease, a condition known as neutropenia occurs, significantly increasing the patient's susceptibility to infections. This is particularly important because infections can lead to serious complications and can delay or interrupt chemotherapy treatment. Therefore, healthcare providers closely monitor neutrophil levels to ensure they are within a safe range, allowing for timely interventions, such as administering growth factors to stimulate neutrophil production or adjusting chemotherapy doses, to prevent the occurrence of severe infections. The other aspects regarding liver function and kidney performance are important in the overall assessment of a patient undergoing chemotherapy, but they are not the primary focus when closely monitoring neutrophil counts. Additionally, while determining the efficacy of chemotherapy is critical, it typically involves evaluating tumor markers, imaging studies, and clinical response rather than the direct counts of neutrophils.

Monitoring neutrophil counts during chemotherapy is crucial primarily to identify the risk of infection due to neutropenia. Chemotherapy often targets rapidly dividing cells, which include not only cancer cells but also normal cells in the bone marrow that produce neutrophils. Neutrophils play a vital role in the body's immune response, particularly in fighting off infections.

When neutrophil levels decrease, a condition known as neutropenia occurs, significantly increasing the patient's susceptibility to infections. This is particularly important because infections can lead to serious complications and can delay or interrupt chemotherapy treatment. Therefore, healthcare providers closely monitor neutrophil levels to ensure they are within a safe range, allowing for timely interventions, such as administering growth factors to stimulate neutrophil production or adjusting chemotherapy doses, to prevent the occurrence of severe infections.

The other aspects regarding liver function and kidney performance are important in the overall assessment of a patient undergoing chemotherapy, but they are not the primary focus when closely monitoring neutrophil counts. Additionally, while determining the efficacy of chemotherapy is critical, it typically involves evaluating tumor markers, imaging studies, and clinical response rather than the direct counts of neutrophils.